NAAS TECHNOLOGY INC-ADR (NAAS)

US62955X2018 - ADR

1.98  -0.03 (-1.49%)

After market: 1.98 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NAAS. NAAS was compared to 122 industry peers in the Specialty Retail industry. NAAS may be in some trouble as it scores bad on both profitability and health. NAAS is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NAAS had negative earnings in the past year.
In the past 5 years NAAS reported 4 times negative net income.
In the past 5 years NAAS always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -89.21%, NAAS is not doing good in the industry: 95.87% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -89.21%
ROE N/A
ROIC N/A
ROA(3y)-469.47%
ROA(5y)-281.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NAAS has a Gross Margin of 27.72%. This is in the lower half of the industry: NAAS underperforms 71.07% of its industry peers.
In the last couple of years the Gross Margin of NAAS has declined.
The Profit Margin and Operating Margin are not available for NAAS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.7%

2

2. Health

2.1 Basic Checks

NAAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NAAS remains at a similar level compared to 1 year ago.
The number of shares outstanding for NAAS has been increased compared to 5 years ago.
Compared to 1 year ago, NAAS has a worse debt to assets ratio.

2.2 Solvency

NAAS has an Altman-Z score of -8.85. This is a bad value and indicates that NAAS is not financially healthy and even has some risk of bankruptcy.
NAAS has a worse Altman-Z score (-8.85) than 91.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.85
ROIC/WACCN/A
WACC7.04%

2.3 Liquidity

A Current Ratio of 1.40 indicates that NAAS should not have too much problems paying its short term obligations.
NAAS's Current ratio of 1.40 is in line compared to the rest of the industry. NAAS outperforms 51.24% of its industry peers.
A Quick Ratio of 1.37 indicates that NAAS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.37, NAAS belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.37

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.19% over the past year.
NAAS shows a strong growth in Revenue. In the last year, the Revenue has grown by 244.91%.
Measured over the past years, NAAS shows a very negative growth in Revenue. The Revenue has been decreasing by -24.11% on average per year.
EPS 1Y (TTM)80.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)244.91%
Revenue growth 3YN/A
Revenue growth 5Y-24.11%
Sales Q2Q%N/A

3.2 Future

NAAS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.74% yearly.
NAAS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 230.16% yearly.
EPS Next Y96.36%
EPS Next 2Y41.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year333.68%
Revenue Next 2Y230.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NAAS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NAAS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NAAS's earnings are expected to grow with 41.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NAAS!.
Industry RankSector Rank
Dividend Yield N/A

NAAS TECHNOLOGY INC-ADR

NASDAQ:NAAS (12/20/2024, 8:26:25 PM)

After market: 1.98 0 (0%)

1.98

-0.03 (-1.49%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-24 2024-10-24
Earnings (Next)N/A N/A
Inst Owners7.71%
Inst Owner Change73.72%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.81M
Analysts82.86
Price Target97.92 (4845.45%)
Short Float %5.81%
Short Ratio2.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.23%
PT rev (3m)3.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-13.7
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.24
BVpS-0.48
TBVpS-1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -89.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.72%
FCFM N/A
ROA(3y)-469.47%
ROA(5y)-281.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.7%
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.37
Altman-Z -8.85
F-ScoreN/A
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y96.36%
EPS Next 2Y41.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)244.91%
Revenue growth 3YN/A
Revenue growth 5Y-24.11%
Sales Q2Q%N/A
Revenue Next Year333.68%
Revenue Next 2Y230.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A